Notably, the levels of HK2 and the number of cells that have subcellular co-localization of HK2 and NOX2 were significantly increased in patients with GBM relative to those in G2 and G3 gliomas (G2, G3) (Figure 4d,e). This evidence concerns the gene HK2 and glioblastoma.